Astemizole has gained great interest as a potential anticancer drug because it targets several proteins involved in cancer including the Eag1 (ether à-go-go-1) potassium channel that is overexpressed in many cancers and is strongly related to carcinogenesis and tumor progression [34,35]. Here, KCNH1 is linked to neoplasm.